Author: Crawford Bruce Yeung Chi-Kit Tanaka Erika Kraemer Matthias Leteneux Claudia
Publisher: Informa Healthcare
ISSN: 1473-7167
Source: Expert Review of Pharmacoeconomics and Outcomes Research, Vol.12, Iss.6, 2012-12, pp. : 765-773
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Short-Term Therapy for Patients with Hepatitis C Virus Genotype 2 or 3 Infection
By Dalgard Olav
Drugs, Vol. 66, Iss. 14, 2006-01 ,pp. :
Emerging therapies for hepatitis C virus
By Birerdinc Aybike Younossi Zobair M
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. :
Clinical virology of hepatitis C virus
By Chevaliez Stéphane Pawlotsky Jean-Michel
Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. :